BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Farmers Insurance
Argus Health
Johnson and Johnson
Chubb
Moodys
Express Scripts
Dow
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

HALCION Drug Profile

« Back to Dashboard

Which patents cover Halcion, and what generic alternatives are available?

Halcion is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in HALCION is triazolam. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the triazolam profile page.
Drug patent expirations by year for HALCION
Pharmacology for HALCION
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for HALCION

US Patents and Regulatory Information for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Accenture
Mallinckrodt
Colorcon
Moodys
Merck
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot